|
Registro Completo |
|
Biblioteca(s): |
Embrapa Caprinos e Ovinos. |
|
Data corrente: |
01/02/2016 |
|
Data da última atualização: |
01/02/2016 |
|
Autoria: |
BROOKS, D. L.; EAST, N. E. |
|
Título: |
Monensin medicated feed as an anticoccidial in young dairy goats. |
|
Ano de publicação: |
1982 |
|
Fonte/Imprenta: |
In: INTERNATIONAL CONFERENCE ON GOAT PRODUCTION AND DISEASE, 3., 1982, Tucson. Proceedings... Scottsdale: Dairy Goat Journal, 1982. p. 565. |
|
ISBN: |
0930848179. |
|
Idioma: |
Inglês |
|
Conteúdo: |
The most common cause of diarrhea in two to seven-month-old dairy goats housed in confined quarters is coccidiosis. Recent trials indicated that monensin, the avian coccidiostatic antibiotic and feedlot cattle growth stimulant, provided protection and some therapeutic effects against coccidiosis in goats. Most goats harbor a few coccidia and, once infected, tend to develop an immunity by 9-12 months of age. The presence of a few oocyst does not always justify treatment and may actually benefit by helping the goat to develop an immunity. Clinical signs of diarrhea and weight loss appear during confined housing. No drugs are specifically approved by the FDA as caprine anticoccidials. The cattle drug monensin, at a concentration of 60 grams per pound of premix, is used at a rate of 20 grams per ton of the goats' alfalfa pellets. This dosage of 22 miligrams per kilo of feed is approximately 1 milligram per kilo of the goat's body weight, depending on feed consumption. Clinical signs were observed and eliminated within 4 weeks of use of the medicated feed, the oocysts gradually dropping to non-detectable numbers. The number of fecal oocyst rose again following withdrawal of the drug, suggesting a more static than cidal action. No palatability problems or toxic effects were attributed to monensin in goats during this trial |
|
Thesagro: |
Caprino; Coccidiose; Doença animal; Erradicação. |
|
Thesaurus Nal: |
Coccidiosis; Disease control; Goats. |
|
Categoria do assunto: |
H Saúde e Patologia |
|
Marc: |
LEADER 01988naa a2200217 a 4500
001 2035744
005 2016-02-01
008 1982 bl uuuu u00u1 u #d
100 1 $aBROOKS, D. L.
245 $aMonensin medicated feed as an anticoccidial in young dairy goats.
260 $c1982
520 $aThe most common cause of diarrhea in two to seven-month-old dairy goats housed in confined quarters is coccidiosis. Recent trials indicated that monensin, the avian coccidiostatic antibiotic and feedlot cattle growth stimulant, provided protection and some therapeutic effects against coccidiosis in goats. Most goats harbor a few coccidia and, once infected, tend to develop an immunity by 9-12 months of age. The presence of a few oocyst does not always justify treatment and may actually benefit by helping the goat to develop an immunity. Clinical signs of diarrhea and weight loss appear during confined housing. No drugs are specifically approved by the FDA as caprine anticoccidials. The cattle drug monensin, at a concentration of 60 grams per pound of premix, is used at a rate of 20 grams per ton of the goats' alfalfa pellets. This dosage of 22 miligrams per kilo of feed is approximately 1 milligram per kilo of the goat's body weight, depending on feed consumption. Clinical signs were observed and eliminated within 4 weeks of use of the medicated feed, the oocysts gradually dropping to non-detectable numbers. The number of fecal oocyst rose again following withdrawal of the drug, suggesting a more static than cidal action. No palatability problems or toxic effects were attributed to monensin in goats during this trial
650 $aCoccidiosis
650 $aDisease control
650 $aGoats
650 $aCaprino
650 $aCoccidiose
650 $aDoença animal
650 $aErradicação
700 1 $aEAST, N. E.
773 $tIn: INTERNATIONAL CONFERENCE ON GOAT PRODUCTION AND DISEASE, 3., 1982, Tucson. Proceedings... Scottsdale: Dairy Goat Journal, 1982. p. 565.
Download
Esconder MarcMostrar Marc Completo |
|
Registro original: |
Embrapa Caprinos e Ovinos (CNPC) |
|
